Blog – Page 29 – Scilex Holding

Blog

01 Mar

Sorrento Therapeutics and Scilex Holding, a Majority Owned Subsidiary, Have Entered Into an Exclusive Licensing Term Sheet With Aardvark Therapeutics to Acquire Its ARD-301 For the Treatment of Chronic Pain, Fibromyalgia, and Chronic Long Haul Covid Syndrome

July 15, 2021
Posted by Jitendra

SAN DIEGO, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics (NASDAQ: SRNE, “Sorrento”) and Scilex Holdings Company (“Scilex”), a majority owned subsidiary of Sorrento, have entered into an exclusive licensing term sheet with...

02 Feb

Open-label adhesion performance studies of a new lidocaine topical system 1.8% versus lidocaine patches 5% and lidocaine medicated plaster 5% in healthy subjects.

September 2, 2021
Posted by Jitendra

15 Jan

Current report

November 17, 2022
Posted by Jitendra

14 Jan

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

11 Jan

Current report

November 17, 2022
Posted by Jitendra

08 Jan

Prospectus

November 17, 2022
Posted by Jitendra

06 Jan

Notice of Effectiveness

November 17, 2022
Posted by Jitendra

06 Jan

Registration adding securities to prior Form S-1 registration

November 17, 2022
Posted by Jitendra

06 Jan

Certification

November 17, 2022
Posted by Jitendra

06 Jan

Registration of securities

November 17, 2022
Posted by Jitendra

«‹27 282930 31 ›»